PHE News

Precision’s Goldman and Lakdawalla in WSJ: Look to Major League Baseball for Drug Pricing Insight

In a new commentary appearing in The Wall Street Journal, Precision Health Economics cofounders Dana Goldman and Darius Lakdawalla turn to the national pastime to provide a fresh perspective on the issue of drug pricing and the return on investment pharmaceutical companies need to sustain innovation.

READ MORE

Maclean Talks Payer Access and New Opportunities Arising From Cures 3037

During the recent ISPOR conference, Ross Maclean, Precision Health Economics' SVP, Head of Medical, sat down to talk with Med Ad News’ Christiane Truelove on new opportunities for payer access in light of new FDA draft guidance around section 3037 of the 21st Century Cures Act.

READ MORE

Jason Shafrin's Blog Named to Top 100 Economics Blogs of 2017 List

For the second year in a row, Precision Health Economics Senior Research Economist Jason Shafrin's blog, "Healthcare Economist," has been named by Intelligent Economist to their list of Top 100 Economics Blogs (worldwide).

READ MORE

Goldman and Jena Discuss the Challenges of Value-Based Pricing in STAT News

In a new commentary for STAT News, PHE co-founder Dana Goldman and scientific advisor Anupam Jena discuss the advantages of value-based pricing, pointing out several of the key challenges that complicate the application of health technology assessments.

READ MORE

PHE's Lakdawalla in LA Times: Providing Perspective on California's Proposed Single-Payer Plan

PHE Co-founder and Chief Scientific Officer Darius Lakdawalla speaks with Melanie Mason from The Los Angeles Times in a new Q&A, discussing the implications of California's new legislation favoring a single-payer healthcare system.

READ MORE
 
  • Academic Insights at

    the Speed of Business

     
  • Intellectual Integrity

    Led by professors at elite research universities, we bring intellectual integrity, academic rigor, and a creative approach to the most challenging problems in heath care.

     
  • Real World Impact

    PHE recommendations have defined and changed national and international payment policies.

     
  • Unparalleled Influence

    We frequently appear in top-tier publications and media outlets-- our work reaches top decision makers and influences outcomes.

     
  • Evidence Generation and

    Commercial Excellence

    As part of Precision for Value, our academic approach to research can be linked with a tailored, commercial approach that demonstrates the value of innovative medications.

     
  • Academic Insights at

    the Speed of Business